Literature DB >> 1125832

Adequacy of commercial lentogenic vaccines against Canadian strains of viscerotropic Newcastle disease virus.

K Kaliannan, G L Seawright, J B Derbyshire.   

Abstract

Three field strains of Newcastle Disease virus, designated S20, S21 and S23, isolated from chickens or turkeys in Ontario during the 1971-72 epizootic, were characterized as velogenic viscerotropic viruses. No significant antigenic differences were demonstrated among B1, LaSota and a field strain (S23) of velogenic vescerotropic virus by haemagglutination inhibition or protection tests. Primary water vaccination of chicks with commercial B1 and LaSota vaccines at five weeks of age and aerosol revaccination with the same strains four weeks later resulted in protection that lasted 16 weeks after revaccination against experimental challenge with strain S23. The differences in haemagglutination inhibition titres noted when the homologous or the heterologous viruses were used as haemagglutinating antigen were not statistically significant. The rates of decay of virus neutralizing and haemagglutination inhibition antibodies in vaccinated birds showed a divergence indicating the possible duality of antibodies measured in serum neutralization and haemagglutination inhibition tests.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1125832      PMCID: PMC1277434     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  6 in total

1.  The pathogenesis of infection with a virulent (CG 179) and an avirulent (B) strain of Newcastle disease virus in the chicken. II. Development of antibody.

Authors:  D T KARZON; F B BANG
Journal:  J Exp Med       Date:  1951-03       Impact factor: 14.307

2.  The viscerotropic pathotype of Newcastle disease virus.

Authors:  R P Hanson; J Spalatin; G S Jacobson
Journal:  Avian Dis       Date:  1973 Apr-Jun       Impact factor: 1.577

3.  Protection of chickens afforded by commercial lentogenic vaccines against challenge exposure to velogenic Newcastle disease virus.

Authors:  W K Butterfield; A H Dardiri; R J Yedloutschnig
Journal:  Avian Dis       Date:  1973 Apr-Jun       Impact factor: 1.577

4.  Aerosol vaccination against Newcastle disease: the influence of vaccine diluent.

Authors:  R E Gough; W H Allan
Journal:  Vet Rec       Date:  1973-10-27       Impact factor: 2.695

5.  Plaque morphology of Newcastle disease virus as influenced by cell type and environmental factors.

Authors:  G Schloer; R P Hanson
Journal:  Am J Vet Res       Date:  1968-04       Impact factor: 1.156

6.  The problem of Newcastle disease.

Authors:  W H Allan
Journal:  Nature       Date:  1971-11-19       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.